Optic glioma warranting treatment in children

Eye

Volumn 20, Issue 10, 2006, Pages 1149-1164

  Kaufman, L M ^a   Doroftei, O ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Chemotherapy; Childhood; Juvenile pilocytic astrocytoma; Optic pathway glioma; Treatment

Indexed keywords

CARBOPLATIN; LOMUSTINE; PROCARBAZINE; TIOGUANINE; VINCRISTINE;

CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL STUDY; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC IMAGING; ENUCLEATION; EXCISION; EXOPHTHALMOS; GAZE; HUMAN; INFANT; MEDICAL RECORD REVIEW; NEUROFIBROMATOSIS; NYSTAGMUS; OPTIC NERVE GLIOMA; OUTPATIENT DEPARTMENT; PRESCHOOL CHILD; RETROSPECTIVE STUDY; TUMOR BIOPSY; VISUAL IMPAIRMENT;

EID: 33749493856     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6702379     Document Type: Conference Paper

References (43)

1. Pollack IF. Brain tumors in children. N Engl J Med 1994; 331: 1500-1507.
2. Listernick R, Darling C, Greenwald M, Strauss L, Charrow J. Optic pathway tumors in children: The effect of neurofibromatosis type 1 on clinical manifestations and natural history. J Pediatr 1995; 127: 718-722.
3. Lewis RA, Gerson LP, Axelson KA, Riccardi VM, Whitford RP. Von Recklinghausen neurofibromatosis. II. Incidence of optic gliomata. Ophthalmology 1984; 91: 929-935.
4. Listernick R, Charrow J, Greenwald M, Mets M. Natural history of optic pathway tumors in children with neurofibromatosis type 1: A longitudinal study. J Pediatr 1994; 125: 63-66.
5. Hoyt WF, Baghdassarian SA. Optic glioma of childhood: Natural history and rationale for conservative management. Br J Ophthalmol 1969; 53: 793-798.
6. Balcer LJ, Liu GT, Heller G, Bilaniuk L, Volpe NJ, Galetta SL et al. Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: Relation to tumor location by magnetic resonance imaging. Am J Ophthalmol 2001; 131: 442-445.
7. Alvord EC, Lofton S. Gliomas of the optic nerve or chiasm: Outcome by patient's age, tumor site, and treatment. J Neurosurg 1988; 68: 85-98.
8. Parsa C, Hoyt C, Lesser R, Weinstein J, Strother C, Muci-Mendoza R et al. Spontaneous regression of optic gliomas. Arch Ophthalmol 2001; 119: 516-529.
9. Liu G, Lessell S. Spontaneous visual improvement in chiasmal gliomas. Am J Ophthalmol 1992; 114: 193-201.
10. Silva MM, Goldman S, Keating G, Marymont MA, Kalapurakal J, Tomita T. Optic pathway hypothalamic gliomas in children under three years of age: the role of chemotherapy. Pediat Neurosurg 2000; 33: 151-158.
11. Packer RJ, Sutton LN, Bilaniuk LT, Radcliffe J, Rosenstock JG, Siegel KR et al. Treatment of chiasmatic/hypothalamic gliomas of childhood with chemotherapy: An update. Ann Neurol 1988; 23: 79-85.
12. Kretschmar CS, Linggood RM. Chemotherapeutic treatment of extensive optic pathway tumors in infants. J Neuro Oncol 1991; 10: 263-270.
13. Laithier V, Grill J, Le Deley MC, Ruchoux MM, Couanet D, Doz F et al. Progression-free survival in children with optic pathway tumors: dependence on age and the quality of the response to chemotherapy - results of the first French prospective study for the French Society of Pediatric Oncology. J Clin Oncol 2003; 21: 4572-4578.
14. Thiagalingam S, Flaherty M, Billson F, North K. Neurofibromatosis type 1 and optic pathway gliomas: Follow-up of 54 patients. Ophthalmology 2004; 111: 568-577.
15. Astrup J. Natural history and clinical management of optic pathway glioma. Br J Neurosurg 2003; 17: 327-335.
16. Singhal S, Birch JM, Kerr B, Lashford L, Evans DG. Neurofibromatosis type 1 and sporadic optic gliomas. Arch Dis Child 2002; 87: 65-70.
17. Khafaga Y, Hassounah M, Kandil A, Kanaan I, Allam A, Husseiny G et al. Optic gliomas: A retrospective analysis of 50 cases. Int J Radiat Oncol Biol Phys 2003; 56: 807-812.
18. Janss AJ, Grundy R, Cnaan A, Savino PJ, Packer RJ, Zachai EH et al. Optic pathway and hypothalamic/chiasmatic gliomas in children younger than age 5 years with a 6-year follow-up. Cancer 1995; 15: 1051-1059.
19. Quinn JA, Reardon DA, Friedman AH, Rich JN, Sampson JH, Provenzale JM et al. Phase II trial of temozolomide in patients with progressive low-grade glioma. J Clin Oncol 2003; 21: 646-651.
20. Tow SL, Chandela S, Miller NR, Avellino AM. Long-term outcome in children with gliomas of the anterior visual pathway. Pediatr Neurol 2003; 28: 262-270.
21. Rush JA, Younge BR, Campbell RJ, MacCarty CS. Optic glioma. Long-term follow-up of 85 histopathologically verified cases. Ophthalmology 1982; 89: 1213-1219.
22. Cawthon RM, Weiss R, Xu GF, Viskochil D, Culver M, Stevens J et al. A major segment of the neurofibromatosis type 1 gene: CDNA sequence, genomic structure, and point mutations. Cell 1990; 62: 193-201.
23. Dasgupta B, Gutmann DH. Neurofibromin regulates neural stem cell proliferation, survival, and astroglial differentiation in vitro and in vivo. J Neurosci 2005; 25: 5584-5594.
24. Ward BA, Gutmann DH. Neurofibromatosis 1: From lab bench to clinic. Pediatr Neurol 2005; 32: 221-228.
25. Gutmann DH, Donahoe J, Brown T, James CD, Perry A. Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas. Neuropathol Appl Neurobiol 2000; 26: 361-367.
26. Platten M, Giordano MJ, Dirven CM, Gutmann DH, Louis DN. Up-regulation of specific NF1 gene transcripts in sporadic pilocytic astrocytomas. Am J Pathol 1996; 149: 621-627.
27. Johannessen CM, Reczek EE, James MF, Brems H, Legius E, Cichowski K. The NF1 tumor suppressor critically regulates TSC2 and mTOR. Proc Natl Acad Sci USA 2005; 102: 8573-8578.
28. Kluwe L, Hagel C, Tatagiba M, Thomas S, Stavrou D, Ostertag H et al. Loss of NF1 alleles distinguish sporadic from NF1-associated pilocytic astrocytomas. J Neuropathol Exp Neurol 2001; 60: 917-920.
29. Dasgupta B, Yi Y, Hegedus B, Weber JD, Gutmann DH. Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma. Cancer Res 2005; 65: 9843-9850.
30. Bredel M, Slavc I, Birner P, Czech T, Haberler C, Strobel T et al. DNA topoisomerase IIalpha expression in optic pathway gliomas of childhood. Eur J Cancer 2002; 38: 393-400.
31. Czyzyk E, Jozwiak S, Roszkowski M, Schwartz R. Optic pathway gliomas in children with and without neurofibromatosis 1. J Child Neurol 2003; 18: 471-478.
32. Lefkowitz IB, Packer RJ, Sutton LN, Siegel KR, Bruce DA, Evans AE et al. Results of the treatment of children with recurrent gliomas with lomustine and vincristine. Cancer 1988; 61: 896-902.
33. Petronio J, Edwards MS, Prados M, Freyberger S, Rabbitt J, Silver P et al. Management of chiasmal and hypothalamic gliomas of infancy and childhood with chemotherapy. J Neurosurg 1991; 74: 701-708.
34. Pons MA, Finlay JL, Walker RW, Puccetti D, Packer RJ, McElwain M. Chemotherapy with vincristine (VCR) and etoposide (VP-16) in children with low-grade astrocytoma. J Neurooncol 1992; 14: 151-158.
35. Packer RJ, Lange B, Ater J, Nicholson HS, Allen J, Walker R et al. Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood. J Clin Oncol 1993; 11: 850-856.
36. Charrow J, Listernick R, Greenwald MJ, Das L, Radkowski MA. Carboplatin-induced regression of an optic pathway tumor in a child with neurofibromatosis. Med Pediatr Oncol 1993; 21: 680-684.
37. Kato T, Sawamura Y, Tada M, Ikeda J, Ishii N, Abe H. Cisplatin/ vincristine chemotherapy for hypothalamic/visual pathway astrocytoma in young children. J Neurooncol 1998; 37: 263-270.
38. Walter AW, Gajjar A, Reardon DA, Thompson SJ, Langston JW, Jones-Wallace D et al. Tamoxifen and carboplatin for children with low-grade gliomas: a pilot study at St Jude Children's Research Hospital. J Pediatr Hematol Oncol 2000; 22: 247-251.
39. Kuo DJ, Weiner HL, Wisoff J, Miller DC, Knopp EA, Finlay JL. Temozolomide is active in childhood, progressive, unresectable, low-grade gliomas. J Pediatr Hematol Oncol 2003; 25: 372-378.
40. Lafay-Cousin L, Holm S, Qaddoumi I, Nicolin G, Bartels U, Tabori U et al. Weekly vinblastine in pediatric low-grade glioma patients with carboplatin allergic reaction. Cancer 2005; 103: 2636-2642.
41. Kortmann RD, Timmermann B, Taylor RE, Scarzello G, Plasswilm L, Paulsen F et al. Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part II: Treatment-related late toxicity. Strahlenther Onkol 2003; 179: 585-597.
42. Marcus KJ, Goumnerova L, Billett AL, Lavally B, Scott RM, Bishop K et al. Stereotactic radiotherapy for localized lowgrade gliomas in children: Final results of a prospective trial. Int J Radiat Oncol Biol Phys 2005; 61: 374-379.
43. Kwon Y, Bae JS, Kim JM, Lee do H, Kim SY, Ahn JS et al. Visual changes after gamma knife surgery for optic nerve tumors. Report of three cases. J Neurosurg 2005; 102: 143-146.